Omada Health (NASDAQ:OMDA) Given New $17.00 Price Target at Barclays

Omada Health (NASDAQ:OMDA) had its target price lowered by Barclays from $22.00 to $17.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 37.43% from the stock’s previous close.

A number of other brokerages also recently weighed in on OMDA. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a research report on Thursday, January 22nd. Weiss Ratings restated a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. The Goldman Sachs Group reissued a “buy” rating and issued a $26.00 target price on shares of Omada Health in a research note on Friday, January 16th. Wells Fargo & Company began coverage on Omada Health in a research report on Thursday, January 8th. They issued an “equal weight” rating and a $17.00 price target for the company. Finally, Evercore raised their target price on Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and an average target price of $24.60.

Omada Health Price Performance

NASDAQ:OMDA traded down $0.53 during mid-day trading on Tuesday, hitting $12.37. The company’s stock had a trading volume of 347,473 shares, compared to its average volume of 1,137,385. The stock has a market cap of $716.35 million and a price-to-earnings ratio of -49.48. The business’s fifty day moving average is $14.21 and its two-hundred day moving average is $18.86. Omada Health has a 1 year low of $10.28 and a 1 year high of $28.40.

Insider Transactions at Omada Health

In related news, CEO Sean P. Duffy sold 40,796 shares of the stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $15.95, for a total transaction of $650,696.20. Following the completion of the transaction, the chief executive officer owned 126,644 shares of the company’s stock, valued at approximately $2,019,971.80. This trade represents a 24.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Wei-Li Shao sold 5,618 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $16.13, for a total value of $90,618.34. Following the completion of the sale, the president directly owned 69,079 shares in the company, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 276,893 shares of company stock valued at $4,336,787.

Hedge Funds Weigh In On Omada Health

Institutional investors have recently bought and sold shares of the company. Quarry LP acquired a new stake in Omada Health during the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. purchased a new stake in shares of Omada Health during the fourth quarter worth $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the second quarter valued at $32,000. Strs Ohio purchased a new position in Omada Health in the third quarter valued at $38,000. Finally, Inlight Wealth Management LLC acquired a new position in Omada Health during the 4th quarter worth $45,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.